作者：
Wang, L. [1]
;
Abbasi, F. [2]
;
Ornatsky, O. [3]
;
Cole, K.D. [4]
;
Misakian, M. [5]
;
Gaigalas, A.K. ;
He, H.-J. ;
Marti, G.E. ;
Tanner, S. ;
Stebbings, R.
作者单位：
Department of Chemistry, University of Toronto, 80 St. George St., Toronto ON, M5S 3H6, Canada
[1]
Division of Cell and Gene Therapies, Laboratory of Stem Cell Biology, Cellular and Tissue Therapy Branch, Office of Cellular, Tissues and Gene Therapies, CBER FDA, NIH Bdg 29B Rm 1NN010, 8800 Rockville Pike, Bethesda, MD 20892, United States
[2]
Biotherapeutics Group, National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, United Kingdom
[3]
Division of Immunology and Hematology Devices, Heme/Path Branch, Office of In Vitro Diagnostic Device Evaluation and Safety, CDRH FDA, Building 66, 10903 New Hampshire Avenue, Silver Spring, MD 20993, United States
[4]
Biochemical Science Division, National Institute of Standards and Technology (NIST), 100 Bureau Drive, Stop 8312, Gaithersburg, MD 20899, United States
[5]
发布时间
2013-11-20
换一批
